Kaustubh Bhardwaj, et al. “FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 33, no. 2, June 2026, pp. 963-81, https://doi.org/10.69980/mng8r305.